Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Hydrolases (EC 3) | ||||||
| N-acylneuraminate-9-phosphatase (NANP) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of NANP | |||||
| Induced Change | CMP-N-Acetylneuraminate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that knockout of NANP leads to the decrease of CMP-N-acetylneuraminate levels compared with control group. | |||||
| Pore-forming PNC peptide (PNC) | ||||||
| Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of TP53 | |||||
| Induced Change | CMP-N-Acetylneuraminate concentration: increase (Log2 FC=1.34) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colon cancer [ICD-11: 2B90] | |||||
| Details | It is reported that knockout of TP53 leads to the increase of CMP-N-acetylneuraminate levels compared with control group. | |||||
| Transcription factor (TF) | ||||||
| Forkhead box protein O1 (FOXO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Overexpression of Foxo1 | |||||
| Induced Change | CMP-N-Acetylneuraminate concentration: increase (FC = 1.20) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that overexpression of Foxo1 leads to the increase of CMP-N-acetylneuraminate levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Acetylglucosaminyltransferase 5 (MGAT5) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Knockout of Mgat5 | |||||
| Induced Change | CMP-N-Acetylneuraminate concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Mgat5 leads to the decrease of CMP-N-acetylneuraminate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


